TY  - JOUR
AU  - Núñez-Gil, Iván J
AU  - Olier, Iván
AU  - Feltes, Gisela
AU  - Viana-Llamas, María C
AU  - Maroun-Eid, Charbel
AU  - Romero, Rodolfo
AU  - Fernández-Rozas, Inmaculada
AU  - Uribarri, Aitor
AU  - Becerra-Muñoz, Victor M
AU  - Alfonso-Rodriguez, Emilio
AU  - García-Aguado, Marcos
AU  - Elola, Javier
AU  - Castro-Mejía, Alex
AU  - Pepe, Martino
AU  - Garcia-Prieto, Juan Fortunato
AU  - Gonzalez, Adelina
AU  - Ugo, Fabrizio
AU  - Cerrato, Enrico
AU  - Bondia, Elvira
AU  - Raposeiras-Roubin, Sergio
AU  - Mendez, Jorge L Jativa
AU  - Espejo, Carolina
AU  - López-Masjuan, Álvaro
AU  - Marin, Francisco
AU  - López-Pais, Javier
AU  - Abumayyaleh, Mohammad
AU  - Corbi-Pascual, Miguel
AU  - Liebetrau, Christoph
AU  - Ramakrishna, Harish
AU  - Estrada, Vicente
AU  - Macaya, Carlos
AU  - Fernandez-Ortiz, Antonio
AU  - HOPE COVID-19 Investigators (Cols Appendix)
PY  - 2021
DO  - 10.1016/j.ahj.2021.04.001
UR  - http://hdl.handle.net/10668/17565
T2  - American heart journal
AB  - The use of Renin-Angiotensin system inhibitors (RASi) in patients with coronavirus disease 2019 (COVID-19) has been questioned because both share a target receptor site. HOPE-COVID-19 (NCT04334291) is an international investigator-initiated registry....
LA  - en
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - COVID-19
KW  - Comorbidity
KW  - Female
KW  - Heart Failure
KW  - Hospitalization
KW  - Humans
KW  - Italy
KW  - Male
KW  - Middle Aged
KW  - Outcome Assessment, Health Care
KW  - Prognosis
KW  - Registries
KW  - Respiration, Artificial
KW  - Risk Factors
KW  - SARS-CoV-2
KW  - Severity of Illness Index
KW  - Spain
TI  - Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.
TY  - research article
VL  - 237
ER  -